Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Adverse Events Reporting Bill Approaching Consensus, Slated For Spring

This article was originally published in The Tan Sheet

Executive Summary

A bill requiring mandatory adverse event reporting for dietary supplements and OTC drugs will likely be introduced this spring, according to congressional staffers
Advertisement

Related Content

Supplement Industry Challenges Include Shrinking Claims World – Israelsen
Supplement Industry Challenges Include Shrinking Claims World – Israelsen
Supplement Industry Challenges Include Shrinking Claims World – Israelsen
Trade Groups Make AER Legislation Wish List; Preemption Is Top Priority
Trade Groups Make AER Legislation Wish List; Preemption Is Top Priority
Supplement Coverage Under HSAs, FSAs Advanced By “Tax Parity” Coalition
Supplement Coverage Under HSAs, FSAs Called For In Proposed Legislation
Senators Durbin, Hatch To Work Together On AER Plan

Topics

Advertisement
UsernamePublicRestriction

Register

PS099163

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel